PMGC starts preclinical study of muscle preservation therapy EL-32

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SKA-B
10. PBA

Go back to PMGC starts preclinical study of muscle preservation therapy EL-32
(NASDAQ: ELAB) Delayed: 1.18 -0.1 (7.81%)
Previous Close $1.28    52 Week High $ 
Open $1.14    52 Week Low $ 
Day High $1.24    P/E N/A 
Day Low $1.07    EPS $ 
Volume 1,781,164